Chonnam University researchers have uncovered a fascinating insight into the role of specific HIF isoforms in muscles, shedding light on how these factors influence muscle physiology and metabolism. This discovery not only deepens our understanding of muscle function but also opens up new avenues for treating metabolic disorders, exercise-related issues, and anemia. The study, published in the Journal of Clinical Investigation, highlights the distinct and non-redundant roles of HIF1α and HIF2α in skeletal muscle, challenging the notion of muscle as a mere tissue for movement and instead positioning it as an endocrine organ. The research team, led by Professors Dong-il Kim and Min-Jung Park, employed innovative mouse models to selectively stabilize HIF1α or HIF2α in skeletal muscle, allowing them to compare the two HIF pathways directly. The findings were eye-opening, revealing that despite both HIF1α and HIF2α being oxygen-sensitive transcription factors, they regulate distinct aspects of muscle physiology and systemic metabolism. HIF1α stabilization increased the proportion of oxidative muscle fibers, often associated with endurance, but paradoxically, the mice performed worse on treadmill tests and showed impaired mitochondrial oxidative phosphorylation. This suggests that while the muscle may appear more endurance-like, its underlying energy machinery is compromised. On the other hand, HIF2α activation in mice improved glucose tolerance, reduced weight gain, preserved mitochondrial function, and was associated with lower food intake and higher GLP-1 levels. Perhaps most surprisingly, HIF2α also drove skeletal muscle to produce and secrete erythropoietin (EPO), a hormone typically associated with the kidneys and liver. This discovery indicates that skeletal muscle may be an additional source of EPO production and erythropoiesis when HIF2α is activated, which has significant implications for anemia research and treatment. The study also raises important safety considerations, as pharmacological PHD inhibitors stabilize HIF pathways and are used or investigated for anemia. The authors caution that systemic manipulation of these pathways should be approached with caution, especially given the potential for muscle dysfunction or excessive red blood cell production. In the long term, understanding the differential actions of HIF1α and HIF2α in muscle may pave the way for more precise, isoform-specific strategies to address metabolic disorders, age-related muscle decline, exercise intolerance, and diseases involving impaired oxygen delivery. This research not only reinforces the endocrine role of muscle but also underscores the complexity and importance of HIF isoforms in maintaining muscle health and overall metabolic balance.
